Medical/Pharmaceuticals
JUD care Launches International Partner Program for Its Portable Ward sROOM, a Revolutionary Solution for Patient Isolation
SHENZHEN, China, Oct. 16, 2020 /PRNewswire/ -- JUD care, a leading high-tech enterprise in the field of smart medical and healthcare solutions, has kicked off its international partner program for its newly-launched portable ward sRoom ("sRoom"), a revolutionary solution for patient isolation tha...
2020-10-16 18:49
4344
Kazia Executes Agreement To Commence GBM Agile Pivotal Study
SYDNEY, Oct. 16, 2020 /PRNewswire/ -- Kazia Therapeutics Limited (ASX: KZA; NASDAQ: KZIA), an Australian oncology-focused biotechnology company, is pleased to announce that it has executed a definitive agreement with the Global Coalition for Adaptive Research (GCAR) to commence Kazia's participat...
2020-10-16 07:30
12565
Galapagos and Servier report topline results for ROCCELLA Phase 2 clinical trial with GLPG1972/S201086 in knee osteoarthritis patients
MECHELEN, Belgium and PARIS, Oct. 16, 2020 /PRNewswire/ -- Servier and Galapagos NV report that no signal of activity was observed in the topline results in their ROCCELLA Phase 2 trial with GLPG1972/S201086. ROCCELLA is a global, double-blind, placebo-controlled, dose ranging trial evaluating t...
2020-10-16 05:09
2859
Mindray Brings Groundbreaking New Systems to the High-End Anesthesia System Market
SHENZHEN, China, Oct. 15, 2020 /PRNewswire/ -- Mindray (SZSE: 300760), a global leader in the development of innovative healthcare technology, hosts a virtual launch event on October 15 to introduce its brand new A9 and A8 anesthesia systems, which is now available inEurope and other selected ...
2020-10-15 21:30
12352
Insilico partners with Taisho on end-to-end AI-powered senolytic drug discovery
HONG KONG, Oct. 15, 2020 /PRNewswire/ -- Insilico Medicine announced today that Taisho Pharmaceutical Co., Ltd. and Insilico have entered into a research collaboration to identify novel therapeutics against aging. Insilico Medicine will utilize both the target discovery and generative chemistry p...
2020-10-15 21:00
4480
AGC Biologics Shifts Leadership Structure at United States and Copenhagen Sites to Support the Continued Development and Growth of the Regions
SEATTLE, Oct. 15, 2020 /PRNewswire/ -- AGC Biologics, a leading global biopharmaceutical contract development and manufacturing organization (CDMO), has announced a leadership update atthe United States and Copenhagen facilities. The changes are being made to strengthen the strategic development ...
2020-10-15 20:00
3643
Covis Group S.à r.l. Announces Commencement of Tender Offer for All Outstanding Shares of AMAG Pharmaceuticals, Inc.
LUXEMBOURG and ZUG, Switzerland, Oct. 15, 2020 /PRNewswire/ -- Covis Group S.à r.l. ("Covis") announced the commencement of a cash tender offer to purchase all of the outstanding shares of common stock of AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) ("AMAG"). The tender offer is being made pursuant ...
2020-10-15 19:30
12595
Gilead Sciences Presents Findings from Clinical Studies Evaluating Patients Who Switched to Biktarvy(R) at 2020 Asia Pacific AIDS & Co-infections Conference
HONG KONG, Oct. 15, 2020 /PRNewswire/ -- Gilead Sciences, Inc. (Nasdaq: GILD) today announced findings from multiple studies in Asian population that evaluated the safety and efficacy of switching to once-daily, single tablet regimen, Biktarvy® (bictegravir 50 mg/emtricitabine 200 mg/tenofovir...
2020-10-15 14:10
7556
Thrive Bioscience Launches the CellAssist to Provide Imaging, Analytics, and Documentation for Reproducible Cell Culture
WAKEFIELD, Massachusetts, Oct. 15, 2020 /PRNewswire/ -- Thrive Bioscience introduces the CellAssist® which enables cell culture researchers to image, analyze, and document all cells, plates, reagents, and workflow details in a centralized database. The CellAssist was developed by Thrive Biosci...
2020-10-15 11:00
3824
Antengene Announces Collaboration with WuXi Biologics to Advance the Development of Innovative Oncology Medicines
SHANGHAI, Oct. 10, 2020 /PRNewswire/ -- Antengene Corporation, a leading innovative biopharmaceutical company dedicated to discovering, developing and commercializing global first-in-class and/or best-in-class therapeutics in hematology and oncology, and WuXi Biologics ("WuXi Bio") (2269.HK) a...
2020-10-15 08:59
2766
Mölnlycke launches new skin-friendly Biogel® surgical gloves to reduce the risk of allergic contact dermatitis for surgeons and nurses
GOTHENBURG, Sweden, Oct. 15, 2020 /PRNewswire/ -- Mölnlycke is celebrating World Handwashing Day with the global launch of the innovative Biogel® PI UltraTouch® S surgical glove, which addresses the problem of allergic contact dermatitis among surgical teams.[1] The latest addition to the industr...
2020-10-15 06:00
2618
CUREMARK Honored by Goldman Sachs for Entrepreneurship
Dr. Joan M. Fallon, CEO and Founder Among 100 Most Intriguing Entrepreneurs at 2020 Builders + Innovators Summit RYE BROOK, New York, Oct. 15, 2020 /PRNewswire/ -- Goldman Sachs (NYSE: GS) is recognizing Curemark's Founder and CEO Dr.Joan M. Fallon as one of the 100 Most Intriguing Entrepreneur...
2020-10-15 03:22
10008
Hyperfine Lauded by Frost & Sullivan for Developing the World's Only Portable MRI System for Point of Care
Designed to deliver both value and performance, the Swoop™ Portable MRI system maximizes operational efficiencies and enables cost-effective quality care LONDON, Oct. 14, 2020 /PRNewswire/ -- Based on its recent analysis of the global portable magnetic resonance imaging (MRI) market, Frost & Sull...
2020-10-14 21:30
2521
Broncus Holding Company Closes Series C Financing
HANGZHOU, China, Oct. 14, 2020 /PRNewswire/ -- Broncus Holding Company ("Broncus"), a global leader in diagnostic and therapeutic technology for lung diseases, today announced the closing of a Series C round of funding led by Lake Bleu Capital, and including Baidu Capital, the venture arm of one ...
2020-10-14 11:32
3408
SK Biopharmaceuticals, Ono Pharmaceutical Enter Licensing Agreement for Cenobamate in Japan
PANGYO, Gyeonggi Province, Korea, Oct. 13, 2020 /PRNewswire/ -- SK Biopharmaceuticals and Ono Pharmaceutical announced that they have entered into an exclusive licensing agreement for Ono to develop and commercialize cenobamate inJapan. Cenobamate is a treatment for partial-onset seizures (POS) ...
2020-10-13 21:00
3760
QYNAPSE (France) and TRUE POSITIVE MEDICAL DEVICES (Canada) are partnering to provide the most advanced AI platform for brain diseases
Strategic partnership in brain imaging and AI PARIS, MONTREAL, and QUEBEC CITY, Oct. 13, 2020 /PRNewswire/ -- * Acquisition of TRUE POSITIVE MEDICAL DEVICES by QYNAPSE * A strategic collaboration that covers 15 patents, including 9 issued in the U.S. andCanada * A unique technology alliance...
2020-10-13 15:00
3619
Envirotainer Unleashes Free Shipment reports
STOCKHOLM, Oct. 13, 2020 /PRNewswire/ -- Envirotainer, the global market leader and the by far largest provider of temperature-controlled air freight solutions for pharmaceuticals, today announced that they open up unlimited and free access to shipment data for all their customers. The shipment d...
2020-10-13 14:38
1950
Antengene's New Drug Discovery Center Established in Zhangjiang, Shanghai: Dedicated to the Research and Development of Innovative Therapies for Cancer
SHANGHAI, Oct. 12, 2020 /PRNewswire/ -- Antengene Corporation, a leading innovative biopharmaceutical company dedicated to discovering, developing and commercializing global first-in-class and/or best-in-class therapies in oncology and hematology, announced today, the official opening of the Ant...
2020-10-12 20:00
4996
AGC Biologics Appoints Luca Alberici as the New General Manager/Site Head of the Milan, Italy Site
SEATTLE, Oct. 12, 2020 /PRNewswire/ -- AGC Biologics, a leading global biopharmaceutical contract development and manufacturing organization (CDMO), has announced a new appointment to initiate integration efforts resulting from theJuly 31, 2020 acquisition of MolMed, a biotechnology company focus...
2020-10-12 20:00
4269
The Covid-19 pandemic is expected to further affect RhoVac's clinical phase IIb study
LUND, Sweden, Oct. 12, 2020 /PRNewswire/ -- RhoVac AB ("RhoVac") announces today that the company's clinical phase IIb study in prostate cancer, a multi-center study with the designation RhoVac-002 ("BRaVac"), is expected to be further delayed due to the prevailing Covid-19 pandemic. The recruitm...
2020-10-12 15:03
2293
Week's Top Stories
Most Reposted
Rocket Travel by Agoda Shares Revealing New Report and Showcases Solution to Transform Hotel Distribution
[Picked up by 313 media titles]
2024-11-21 10:30Rockwell Automation and Microsoft Deliver on a Shared Vision to Accelerate Industrial Transformation
[Picked up by 308 media titles]
2024-11-20 13:29Durabook and Parent Company, Twinhead International Corp., Celebrate 40 Years of Innovation in Computing Solutions
[Picked up by 301 media titles]
2024-11-20 16:30
Travel loyalty programs to focus on offering personalized and flexible customer experiences in 2025
[Picked up by 298 media titles]
2024-11-19 10:42Philips and Edith Cowan University Australia Collaborate to Equip the Next Generation of Healthcare Professionals to leverage new technologies
[Picked up by 284 media titles]
2024-11-20 09:00
Most Read
Durabook and Parent Company, Twinhead International Corp., Celebrate 40 Years of Innovation in Computing Solutions
2024-11-20 16:30
7433
Philips and Edith Cowan University Australia Collaborate to Equip the Next Generation of Healthcare Professionals to leverage new technologies
2024-11-20 09:00
6834
